Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 17, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $428.00 to $8,749,928.65.

Highlighted Stocks Traded by Insiders:

Lannett (LCI) - FREE Research Report

Schreck William, who is Coo at Lannett, sold 134,635 shares at $64.99 on March 17, 2015. Following this transaction, the Coo owned 76,880 shares meaning that the stake was reduced by 63.65% with the 134,635-share transaction.

The shares most recently traded at $67.96, up $2.97, or 4.37% since the insider transaction. Historical insider transactions for Lannett go as follows:

  • 4-Week # shares bought: 1,250
  • 4-Week # shares sold: 70,000
  • 12-Week # shares bought: 1,250
  • 12-Week # shares sold: 130,716
  • 24-Week # shares bought: 2,750
  • 24-Week # shares sold: 185,716

The average volume for Lannett has been 755,200 shares per day over the past 30 days. Lannett has a market cap of $2.3 billion and is part of the health care sector and drugs industry. Shares are up 54.94% year-to-date as of the close of trading on Tuesday.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company has a P/E ratio of 18.8. Currently, there are 2 analysts who rate Lannett a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LCI - FREE

TheStreet Quant Ratings rates Lannett as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Lannett Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

United Bankshares (UBSI) - FREE Research Report

Leech Douglas J, who is Director at United Bankshares, sold 15,000 shares at $38.14 on March 17, 2015. Following this transaction, the Director owned 5,959 shares meaning that the stake was reduced by 71.57% with the 15,000-share transaction.

The shares most recently traded at $38.45, up $0.31, or 0.82% since the insider transaction. Historical insider transactions for United Bankshares go as follows:

  • 4-Week # shares bought: 96
  • 4-Week # shares sold: 14,023
  • 12-Week # shares bought: 96
  • 12-Week # shares sold: 14,023
  • 24-Week # shares bought: 910
  • 24-Week # shares sold: 14,023

The average volume for United Bankshares has been 386,700 shares per day over the past 30 days. United Bankshares has a market cap of $2.7 billion and is part of the financial sector and banking industry. Shares are up 2.54% year-to-date as of the close of trading on Tuesday.

United Bankshares, Inc., through its subsidiaries, provides commercial and retail banking services and products in the United States. The stock currently has a dividend yield of 3.35%. The company has a P/E ratio of 19.9. Currently, there is 1 analyst who rates United Bankshares a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UBSI - FREE

TheStreet Quant Ratings rates United Bankshares as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full United Bankshares Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

KCG Holdings (KCG) - FREE Research Report

Daniel V. Tierney 2011 Trust, who is 10% Owner at KCG Holdings, sold 69,800 shares at $12.55 on March 17, 2015. Following this transaction, the 10% Owner owned 8.9 million shares meaning that the stake was reduced by 0.78% with the 69,800-share transaction.

The shares most recently traded at $12.68, up $0.13, or 1.01% since the insider transaction.

The average volume for KCG Holdings has been 302,200 shares per day over the past 30 days. KCG Holdings has a market cap of $1.5 billion and is part of the financial sector and financial services industry. Shares are up 10.9% year-to-date as of the close of trading on Tuesday.

KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other. The company has a P/E ratio of 23.5. Currently, there are 2 analysts who rate KCG Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KCG - FREE

TheStreet Quant Ratings rates KCG Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and relatively poor performance when compared with the S&P 500 during the past year. Get the full KCG Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null